[Multiple eruptive keratoacanthoma disclosing lymphoma]

Ann Dermatol Venereol. 1989;116(11):860-2.
[Article in French]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etretinate / therapeutic use
  • Facial Dermatoses / complications
  • Facial Dermatoses / drug therapy
  • Facial Dermatoses / pathology*
  • Humans
  • Keratoacanthoma / complications
  • Keratoacanthoma / drug therapy
  • Keratoacanthoma / pathology*
  • Lymphoma / complications
  • Lymphoma / diagnosis*
  • Lymphoma / drug therapy
  • Male
  • Mouth Diseases / complications
  • Mouth Diseases / drug therapy
  • Mouth Diseases / pathology*
  • Mouth Mucosa / pathology
  • Prednisolone / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Etretinate
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone

Supplementary concepts

  • VAP-cyclo protocol